Skip to main content

Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials.

Publication ,  Journal Article
Ford, AC; Forman, D; Hunt, RH; Yuan, Y; Moayyedi, P
Published in: BMJ (Clinical research ed.)
May 2014

To determine whether searching for Helicobacter pylori and treating with eradication therapy leads to a reduction in incidence of gastric cancer among healthy asymptomatic infected individuals.Systematic review and meta-analysis of randomised controlled trials.Medline, Embase, and the Cochrane central register of controlled trials were searched through to December 2013. Conference proceedings between 2001 and 2013 were hand searched. A recursive search was performed with bibliographies of relevant studies. There were no language restrictions.Randomised controlled trials examining the effect of at least seven days of eradication therapy on subsequent occurrence of gastric cancer in adults who tested positive for Helicobacter pylori but otherwise healthy and asymptomatic were eligible. The control arm had to receive placebo or no treatment. Subjects had to be followed for ≥ 2 years.Primary outcome, defined a priori, was the effect of eradication therapy on the subsequent occurrence of gastric cancer expressed as a relative risk of gastric cancer with 95% confidence intervals.The search strategy identified 1560 citations, of which six individual randomised controlled trials were eligible. Fifty one (1.6%) gastric cancers occurred among 3294 individuals who received eradication therapy versus 76 (2.4%) in 3203 control subjects (relative risk 0.66, 95% confidence interval 0.46 to 0.95), with no heterogeneity between studies (I(2)=0%, P=0.60). If the benefit of eradication therapy was assumed to persist lifelong the number needed to treat was as low as 15 for Chinese men and as high as 245 for US women.These data provide limited, moderate quality evidence that searching for and eradicating H pylori reduces the incidence of gastric cancer in healthy asymptomatic infected Asian individuals, but these data cannot necessarily be extrapolated to other populations.

Altmetric Attention Stats
Dimensions Citation Stats

Published In

BMJ (Clinical research ed.)

DOI

EISSN

1756-1833

ISSN

0959-8138

Publication Date

May 2014

Volume

348

Start / End Page

g3174

Related Subject Headings

  • Stomach Neoplasms
  • Randomized Controlled Trials as Topic
  • Outcome and Process Assessment, Health Care
  • Humans
  • Helicobacter pylori
  • Helicobacter Infections
  • General & Internal Medicine
  • Disease Eradication
  • Asymptomatic Infections
  • 52 Psychology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ford, A. C., Forman, D., Hunt, R. H., Yuan, Y., & Moayyedi, P. (2014). Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ (Clinical Research Ed.), 348, g3174. https://doi.org/10.1136/bmj.g3174
Ford, Alexander C., David Forman, Richard H. Hunt, Yuhong Yuan, and Paul Moayyedi. “Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials.BMJ (Clinical Research Ed.) 348 (May 2014): g3174. https://doi.org/10.1136/bmj.g3174.
Ford, Alexander C., et al. “Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials.BMJ (Clinical Research Ed.), vol. 348, May 2014, p. g3174. Epmc, doi:10.1136/bmj.g3174.

Published In

BMJ (Clinical research ed.)

DOI

EISSN

1756-1833

ISSN

0959-8138

Publication Date

May 2014

Volume

348

Start / End Page

g3174

Related Subject Headings

  • Stomach Neoplasms
  • Randomized Controlled Trials as Topic
  • Outcome and Process Assessment, Health Care
  • Humans
  • Helicobacter pylori
  • Helicobacter Infections
  • General & Internal Medicine
  • Disease Eradication
  • Asymptomatic Infections
  • 52 Psychology